zirconium has been researched along with Ovarian Neoplasms in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 3 (23.08) | 2.80 |
Authors | Studies |
---|---|
Brooks, CL; de Stanchina, E; Edwards, KJ; Hollingsworth, MA; Jiao, MS; Keinänen, O; Lewis, JS; Mack, KN; Madiyalakan, MR; Piersigilli, A; Pourat, J; Radhakrishnan, P; Sharma, SK; White, B; Zeglis, BM; Zhao, H | 1 |
Broer, LN; Cole, PE; Cuthbertson, AS; de Groot, DA; de Vries, EGE; Ellingsen, C; Giesen, D; Hagemann, UB; Indrevoll, B; Knapen, DG; Kristian, A; Lub-de Hooge, MN; Moen, I; Suurs, FV; Waaijer, SJH | 1 |
Brown, MP; Donnelly, PS; Evdokiou, A; Gargett, T; Liapis, V; Rudd, SE; Staudacher, AH; Takhar, P; Tieu, W; Wittwer, NL | 1 |
Arjaans, M; de Vries, EG; Garbacik, ET; Gietema, JA; Lub-de Hooge, MN; Oosting, SF; Oude Munnink, TH; Schröder, CP; Terwisscha van Scheltinga, AG; Timmer-Bosscha, H | 1 |
Adam, MJ; Lewis, JS; Orvig, C; Price, EW; Zeglis, BM | 1 |
Bensch, F; Bongaerts, AH; de Jong, JR; de Vries, EG; Fine, BM; Gietema, JA; Glaudemans, AW; Hoekstra, OS; Lamberts, LE; Lub-de Hooge, MN; Maslyar, D; Menke-van der Houven van Oordt, CW; Sanabria Bohorquez, SM; Schröder, CP; Smeenk, MM; ter Weele, EJ; Verheul, HM; Voortman, J; Williams, SP | 1 |
Carlin, SD; Knight, JC; Lewis, JS; Monette, S; Sala, E; Sevak, KK; Sharma, SK; Wuest, FR; Zeglis, BM | 1 |
Gill, HS; Magda, D; Marik, J; N Tinianow, J; Ogasawara, A; Pailloux, SL; Pandya, DN; Vanderbilt, AN; Wadas, TJ; Williams, SP | 1 |
Dongen, GA; Hooge, MN; Jensen, MR; Jong, JR; Korte, MA; Nagengast, WB; Oude Munnink, TH; Quadt, C; Schröder, CP; Timmer-Bosscha, H; Vries, EG | 1 |
de Jong, JR; de Korte, MA; de Vries, EG; den Dunnen, WF; Garcia-Echeverria, C; Hollema, H; Jensen, MR; Lub-de Hooge, MN; Nagengast, WB; Oude Munnink, TH; Quadt, C; Schröder, CP; Timmer-Bosscha, H; van Dongen, GA | 1 |
de Jong, S; de Vries, EG; Kosterink, JG; Lub-de Hooge, MN; Pot, L; Reyners, AK; Schröder, CP; Terwisscha van Scheltinga, AG; Timmer-Bosscha, H; van der Bilt, AR; van der Zee, AG | 1 |
Brouwers, AH; de Jong, JR; de Vries, EG; Hollema, H; Hospers, GA; Lub-de Hooge, MN; Mulder, NH; Nagengast, WB; Perk, LR; van Dongen, GA | 1 |
Hiltbrand, E; Joliat, D; Popowski, Y; Rouzaud, M | 1 |
13 other study(ies) available for zirconium and Ovarian Neoplasms
Article | Year |
---|---|
ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; CA-125 Antigen; Carcinogenesis; Cell Line, Tumor; Female; Humans; Immunoconjugates; Membrane Proteins; Mice; Mucins; Ovarian Neoplasms; Pancreatic Neoplasms; Radioisotopes; Tissue Distribution; Zirconium | 2022 |
Topics: Animals; Apoptosis; Cell Line, Tumor; Chelating Agents; Female; Humans; Immunoconjugates; Mesothelin; Mice; Mice, Nude; Ovarian Neoplasms; Positron-Emission Tomography; Tissue Distribution; Zirconium | 2022 |
Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models.
Topics: Animals; Antibodies, Monoclonal; Cell Death; Cell Line, Tumor; Cisplatin; Electrons; Heterografts; Humans; Lung; Mice; Ovarian Neoplasms; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Zirconium | 2021 |
Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Cell Line, Tumor; Drug Interactions; Esophageal Neoplasms; Female; Humans; Immunoglobulin G; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Trastuzumab; Xenograft Model Antitumor Assays; Zirconium | 2013 |
H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Chelating Agents; Female; Humans; Indium; Isotope Labeling; Lutetium; Mice; Mice, Nude; Organophosphorus Compounds; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Radioisotopes; Trastuzumab; Zirconium | 2014 |
ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment.
Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, Neoplasm; Female; GPI-Linked Proteins; Humans; Immunoconjugates; Male; Mesothelin; Middle Aged; Ovarian Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Zirconium | 2016 |
Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis.
Topics: Animals; Antibodies, Monoclonal; CA-125 Antigen; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Humans; Immunoconjugates; Lymphatic Metastasis; Membrane Proteins; Mice; Ovarian Neoplasms; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Zirconium | 2016 |
Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice.
Topics: Animals; Chelating Agents; Disease Models, Animal; Female; Mice; Ovarian Neoplasms; Positron-Emission Tomography; Pyridones; Radiopharmaceuticals; Zirconium | 2016 |
(89)Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biomarkers, Tumor; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Male; Mice; Mice, Nude; Ovarian Neoplasms; Positron-Emission Tomography; Radioisotopes; Receptor, ErbB-2; Resorcinols; Trastuzumab; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zirconium | 2010 |
89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Cisplatin; Drug Resistance, Neoplasm; Female; HSP90 Heat-Shock Proteins; Immunohistochemistry; Isoxazoles; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Ovarian Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Resorcinols; Tissue Distribution; Vascular Endothelial Growth Factor A; Zirconium | 2010 |
Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Biomarkers, Tumor; Cell Line, Tumor; Everolimus; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Sirolimus; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays; Zirconium | 2012 |
In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line, Tumor; Female; Humans; Immunohistochemistry; Indium Radioisotopes; Isotope Labeling; Male; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Quality Control; Radiopharmaceuticals; Transplantation, Heterologous; Vascular Endothelial Growth Factor A; Zirconium | 2007 |
Open magnetic resonance imaging using titanium-zirconium needles: improved accuracy for interstitial brachytherapy implants?
Topics: Adult; Aged; Aged, 80 and over; Biocompatible Materials; Brachytherapy; Carcinoma, Squamous Cell; Feasibility Studies; Female; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Needles; Ovarian Neoplasms; Phantoms, Imaging; Titanium; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Neoplasms; Zirconium | 2000 |